Morbidity of breast cancer, and death rate from it in Tashkent during 2012–2022

Background. In the developed countries breast cancer (BC) is the most frequent form of localization of malignant neoplasms at women.Aim. The analysis of BC morbidity and death rates from it in Tashkent for 2012–2022 in intensive (IR) and standardized rates (SR) in the international standard of World Health Organization.Materials and methods. Data of cancer-register which is functioning at organizational-statistical department of the Tashkent City Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Ministry of Health of the Republic of Uzbekistan were studied. The IR and SR of morbidity of BC and death rates from it in Tashkent are calculated.Results. The female morbidity by malignant neoplasms (in IR) in Tashkent city gradually growth during 2012–2022, and it some decreases in 2020. SR in 2020 (the basic year of pandemic COVID-19) there was “splash” in 2020 morbidity by malignant neoplasms, in particular, BC, and SR of death rate from them among the female population of Tashkent in comparison with other years of this period. This occurred at the expense of increase of their frequencies (mainly) in women aged 45–64 years and older.Conclusion. Detected facts are connected with practice of diagnostics and treatment of BC on the basis of spontaneous reference to a doctor of the population (generated in Uzbekistan for the last decades) and by absence of regular practice of early diagnostics Bс (screening). These facts are important for further development of system of control of BC in Tashkent.